Skip to main content

Table 8 Sensitivity analysis of the PWP-TT model (arm B)

From: Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs

Variable

Hazard Ratio (95% CI)

On randomised drug only

Recurrent tonic-clonic seizures only

On randomised drug only & recurrent tonic-clonic seizures only

Gender

Female

Male

1.00

1.29 (1.22, 1.36)

1.00

1.29 (1.19, 1.39)

1.00

1.28 (1.14, 1.44)

Febrile Seizure History

Absent

Present

N/A

1.00

0.82 (0.71, 0.95)

1.00

1.33 (1.09, 1.63)

First degree relative with epilepsy

Absent

Present

1.00

1.21 (1.14, 1.30)

N/A

1.00

1.55 (1.37, 1.75)

Treatment History

Treat. naïve

Seizures

Not SANAD AED

1.00

0.81 (0.68, 0.97)

1.45 (1.31, 1.61)

1.00

0.68 (0.53, 0.87)

1.08 (0.97, 1.21)

1.00

1.09 (0.79, 1.50)

1.46 (1.24, 1.72)

Neurological Insult

Absent

Present

N/A

1.00

1.17 (1.04, 1.31)

1.00

0.79 (0.66, 0.93)

EEG Result

Normal

Epi. abnorm.

N/S abnorm.

Not indicated

1.00

0.77 (0.64, 0.93)

0.75 (0.65, 0.85)

1.19 (1.11, 1.29)

1.00

0.74 (0.63, 0.87)

0.61 (0.53, 0.70)

0.83 (0.76, 0.91)

1.00

1.01 (0.75, 1.35)

0.65 (0.54, 0.80)

1.08 (0.95, 1.23)

Age at randomisation (years)

≤7

8–13

14–19

20–27

28–50

> 50

1.00

0.94 (0.93, 0.95)

0.89 (0.87, 0.91)

0.85 (0.82, 0.88)

0.80 (0.76, 0.84)

0.75 (0.71, 0.80)

1.00

0.96 (0.94, 0.97)

0.92 (0.88, 0.95)

0.89 (0.84, 0.93)

0.85 (0.79, 0.91)

0.81 (0.74, 0.89)

1.00

0.98 (0.95, 1.00)

0.96 (0.91, 1.01)

0.94 (0.88, 1.01)

0.92 (0.84, 1.01)

0.90 (0.80, 1.02)

Annual rate seizures prior to randomisation

1

1–2

2–6

> 6

N/A

1.00

0.99 (0.98, 1.00)

0.98 (0.96, 1.00)

0.96 (0.92, 0.99)

N/A

Seizure type

Gen. TC

Absence

Myo./Abs + TC

Unclass. TC

Other

1.00

1.14 (1.04, 1.26)

1.12 (1.03, 1.22)

1.00 (0.91, 1.11)

0.96 (0.85, 1.07)

1.00

1.04 (0.84, 1.30)

1.43 (1.30, 1.57)

1.11 (1.00, 1.23)

1.45 (1.24, 1.70)

1.00

0.88 (0.69, 1.12)

1.51 (1.32, 1.73)

1.02 (0.88, 1.18)

1.56 (1.25, 1.95)

Treatment

Valproate

Lamotrigine

Topiramate

1.00

1.26 (1.18, 1.34)

1.61 (1.50, 1.73)

1.00

1.24 (1.14, 1.36)

1.29 (1.18, 1.42)

1.00

1.57 (1.38, 1.79)

2.16 (1.88, 2.47)

  1. N/A – variable not included in multivariable model; Epi. abnorm. – epileptiform abnormality;
  2. N/S abnorm. – non-specific abnormality; gen. TC – generalised tonic-clonic; myo./abs + TC – myoclonic or absence with tonic-clonic; unclass. TC – unclassified tonic-clonic